Efficacy and Safety Profile of Histone Deacetylase Inhibitors for Metastatic Breast Cancer: A Meta-Analysis.

Wang, Changjun; Lin, Yan; Zhu, Hanjiang; Zhou, Yidong; Mao, Feng; Huang, Xin; Sun, Qiang; Li, Chenggang

Wang, Changjun; Lin, Yan; Zhu, Hanjiang; Zhou, Yidong; Mao, Feng; Huang, Xin; Sun, Qiang; Li, Chenggang.

Afiliação

Wang C; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Lin Y; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Zhu H; Department of Dermatology, University of California San Francisco, San Francisco, CA, United States.
Zhou Y; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Mao F; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Huang X; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Sun Q; Department of Breast Surgery, Peking Union Medical College Hospital, Beijing, China.
Li C; State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.

Front Oncol ; 12: 901152, 2022.

Article em En | MEDLINE | ID: mdl-35712478

Palavras-chave

endocrine therapy; entinostat; histone deacetylase inhibitors; metastatic breast cancer; tucidinostat

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google